Cutaneous Fungal Infections: Accurate Diagnosis, Mycological Testing & Targeted Antifungals

Cutaneous fungal infections are among the most frequently misdiagnosed dermatological conditions. Prescribing topical corticosteroid creams to a fungal infection creates 'Tinea Incognito'—suppressing inflammation while allowing fungal hyphae to invade unchecked.

Spectrum of Fungal Pathogens

Cutaneous mycoses generally divide into three major classes:

• Dermatophytes: Keratinophilic fungi (Trichophyton, Microsporum, Epidermophyton) that feed on keratin in the stratum corneum, nails, and hair shafts, producing classical annular plaques with active, elevated erythematous borders (Tinea Corporis, Tinea Pedis, Tinea Capitis).
• Yeasts (Malassezia species): Commensal dimorphic yeasts that transform into opportunistic pathogens under warm, humid conditions, causing Pityriasis Versicolor (hypopigmented or hyperpigmented macules) and Seborrheic Dermatitis.
• Candida: Opportunistic yeasts producing macerated, bright red intertriginous plaques with characteristic surrounding satellite pustules.

Definitive Diagnosis: Potassium Hydroxide (KOH) & Culture

Before initiating therapy, active border scrapings examined under direct microscopy with 10–20% KOH reveal branching septate hyphae or yeast blastospores within minutes, preventing inappropriate steroid treatment.

Targeted Antifungal Protocols

Superficial localized tinea responds well to topical allylamines (Terbinafine) or imidazoles (Clotrimazole, Ketoconazole). Extensive, tinea capitis, or onychomycosis cases mandate targeted oral antifungal courses with Terbinafine or Itraconazole accompanied by baseline hepatic screening.